Genmab A/S
LSE:0MGB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genmab A/S
LSE:0MGB
|
DK |
|
W
|
W5 Solutions AB (publ)
F:EY7
|
SE |
|
Red 5 Ltd
ASX:RED
|
AU |
|
Kuraray Co Ltd
TSE:3405
|
JP |
|
A
|
Americas Gold and Silver Corporation
F:SZ71
|
CA |
|
B
|
Berner Kantonalbank AG
LSE:0QM2
|
CH |
|
Pointerra Ltd
ASX:3DP
|
AU |
|
One REIT Inc
TSE:3290
|
JP |
|
Assa Abloy AB
STO:ASSA B
|
SE |
|
BioRestorative Therapies Inc
NASDAQ:BRTX
|
US |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
XBER:AUS
|
AT |
|
F
|
Fiverr International Ltd
F:11V
|
IL |
|
GeneDx Holdings Corp
NASDAQ:WGS
|
US |
|
A
|
AAK AB (publ)
LSE:0A0J
|
SE |
|
I
|
IWG Plc
OTC:IWGFF
|
CH |
|
Whitehaven Coal Ltd
ASX:WHC
|
AU |
Bankruptcy Probability
Genmab A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genmab A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Genmab A/S
CSE:GMAB
|
112.2B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genmab A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genmab A/S has total debt of 5.1B DKK. This includes both short-term (0 DKK) and long-term (5.1B DKK) debt.
You can find a full breakdown on its Balance Sheet.
